Rejuvenate Biomed's potential drug candidate combats sarcopenia in older adults
Rejuvenate Biomed - 21-Feb-2024Phase 1b trial shows RJx-01's ability to improve muscle strength, function, and fatigue resistance
Join the club for FREE to access the whole archive and other member benefits.
Phase 1b trial shows RJx-01's ability to improve muscle strength, function, and fatigue resistance
Sarcopenia drug trial shows no evidence of toxicity or safety issues
SARA-INT Phase 2 study and SARA Phase 3 study milestones in developing sarconeos
Potential oral treatment to prevent sarcopenia and frailty, and extend healthy lifespan
Neuromuscular junction: A potential therapeutic target in neuromuscular injury
No resources found!
Don’t fall into the vicious circle of frailty